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Abstract 
Background: We wanted to depict fibers of the dentatorubrothalamic tract in patients with Parkinson’s disease and 
multiple sclerosis in order to use this knowledge for clinical routine and to show its relation to the corticospinal tract 
for deep brain stimulation. Fibers of these white matter tracts were depicted between February 2014 and February 
2015 in nine patients of all ages. There were seven men and two women. The mean age was 60 years. We used a 3DT1 
sequence for the navigation. Additional scanning time was less than 9 min. Both tracts were portrayed in all patients.
Results: We were able to successfully portray these white matter tracts in all patients. We visualized the medial and 
lateral parts of the corticospinal tract by using a region of interest which covered the whole motor cortex. Further‑
more we segmented the motor cortex. The fibers ran from this area of the brain through the internal capsule and they 
could be followed until their entry in the brainstem. The dentatorubrothalamic tract was smaller than the corticospi‑
nal tract. It was situated medio‑posteriorly of the corticospinal tract. After decussation to the contralateral red nucleus 
it was localised next to the midline when it entered the motor cortex. From the thalamus on, it proceeds medially and 
posteriorly of the corticospinal tract further to the motor cortex. Depiction of the whole tract is essential for the dif‑
ferentiation of the dentatorubrothalamic tract with the corticospinal tract.
Conclusions: The depiction of the dentatorubrothalamic tract might be useful for neurosurgeons when deep brain 
stimulation is planned. Knowing its relation to other white matter tracts can help physicians like neurosurgeons or 
neurologists avoid side effects and deal with patients with DBS. The position of the electrode might be crucial for a 
satisfactory outcome.
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Background
PD is a neurodegenerative disease associated with neu-
ropsychiatric illness [1]. It is characterized by the death 
of dopaminergic neurons in the substantia nigra in pars 
compacta [1–3]. Patients present in particular with 
tremor, rigidity and postural instability [4, 5]. Further-
more patients may suffer from nonmotor disorders like 
depression, apathy, psychotic symptoms or sleep disor-
ders [4, 6]. These symptoms might dramatically affect 
the quality of life not only of the patients but also of 
their families. Deep brain stimulation (DBS) is a surgi-
cal procedure which is used in the management of PD 
in patients with inadequate control of symptoms or with 
significant side effects from Levodopa [7, 8]. It delivers 
electrical pulses which are variable in amplitude, pulse 
width, and frequency, through permanently implanted 
electrodes [9, 10]. The importance of electrical current 
for signal transduction was already known to Galvani in 
the eighteenth century [7]. It took, however, more than 
two centuries until we were able to use it in the form of 
DBS for patients with PD. By means of DBS we are able to 
inhibit or activate a target in the brain [7]. Possible thera-
peutic targets include the subthalamic nucleus, the glo-
bus pallidus internus or the ventral intermediate nucleus 
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of thalamus [7]. Most targets aim the improvement of 
motor symptoms of PD and the DBS is used for tremor of 
various origins [11] but there is still work necessary to be 
done for the correction of nonmotor symptoms of PD [7, 
12]. Apart from that there still seems to be no concensus 
between neurosurgeons about the best target in cases of 
tremor dominant PD with some of them advocating the 
ventral intermediate nucleus of the thalamus and others 
preferring the subthalamic nucleus.
Diffusion tensor imaging (DTI) is a technique that 
enables neurosurgeons to portray white matter tracts 
(WMT) in  vivo in healthy and non-healthy patients 
[13]. It can be used in a variety of diseases among oth-
ers tumours, multiple sclerosis or neurodegenerative 
diseases like PD [14]. Furthermore DTI can reveal pre-
viously unexplained side effects of DBS towards distinct 
fiber tracts [11, 15]. Some of the WMT portrayed by 
the DTI include the visual pathway, corticospinal tract 
(CST) or the dentatorubrothalamic tract (DRT). The lat-
ter is the main fiber bundle that forms the superior cer-
ebellar peduncle [11, 16]. Affection of this WMT might 
be the reason for tremor control in patients with PD in 
the posterior subthalamic region [11, 17]. The aim of 
our study was to visualize fibers of the DRT before sur-
gery in patients with PD for everyday routine. Further-
more we deem necessary to know the relation between 
this WMT and the CST. The DRT seems to be a target 
point for patients who will undergo a DBS. Depending on 
the position of the electrode in the DRT, we might cause 
unwanted side effects due to the proximity of this WMT 
to the CST. Therefore, we portrayed both tracts in all our 
patients in order to have a better understanding of these 
two WMT.
Methods
We included in our study between February 2014 and 
February 2015 nine consecutive patients. These were 
seven men and two women. There was no limit of age. 
The mean age was 60  years. There were eight patients 
suffering from PD and one patient suffering from MS. 
The MRI was performed in order to prepare an even-
tual DBS. An MRI-scan was acquired on a 3T General 
Electric SignaHDxt Scanner preoperatively. We per-
formed a 3DT1-sequence to navigate. Furthermore 
T2-and DTI-sequences were carried out. The FOV was 
200 ×  200  mm2, slice thickness 2  mm, and the acquisi-
tion matrix of 96  ×  96 yielding nearly isotropic voxels 
of 2 ×  2 ×  2 mm. 3T-MRI was performed strictly axial 
using 32 gradient directions and one b0-image. b value 
was 800 s/mm2. We used EchoPlanar-Imaging (EPI) and 
ASSET parallel imaging with an acceleration factor of 2. 
The additional scanning time was less than 9  min. One 
day after surgery a computed tomography of the brain 
was performed. We processed the DTI data on a stand-
ard commercial workstation (StealthViz, Medtronic Inc., 
USA). This software uses a straightforward fiber track-
ing approach known as fiber assignment by continuous 
tracking (FACT). Parameters for the tractographies were 
a maximum angle of 45° for the CST and 60° for the DRT, 
an FA Start Value of 0.10 and an ADC Stop Value of 0.20. 
First we segmented the motor cortex (MC) on both cer-
ebral hemispheres. Then we tracked the CST from this 
area. A region of interest (ROI) was put in the brain stem. 
The fibers were tracked also from the brain stem to the 
MC. It is possible to use a ROI in place of the segmented 
area of the MC. For the DRT we acted in a similar way. 
The fibers were tracked from the dentate nucleus (DN) 
of the cerebellum to the red nucleus of the contralateral 
hemisphere and later to the MC. Therefore, we used 
two ROI. One of them was put in the DN of the cerebel-
lum and the other one in the contralateral red nucleus. 
As mentioned before it is possible to use another ROI 
instead of the segmented area of the MC. In that case 
this white matter tract would be portrayed using three 
ROI. The ROI measured approximately 1  cm in the red 
nucleus and DN of the cerebellum whereas the ROI for 
the MC measured approximately the size of the MC.
Results
Using DTI we were able to successfully portray fib-
ers of two main WMT, the CST and the DRT, in all our 
patients. We visualized the medial and lateral parts of the 
CST by using a ROI which covered the whole MC. A seg-
mentation of the MC was performed in order to enhance 
the accuracy. The fibers ran from this area of the brain 
through the internal capsule and they could be followed 
until their entry in the brainstem. Our main interest was, 
however, the portrayal of the DRT. This WMT begins in 
the DN of the cerebellum. The fibers arise from the DN 
dorsolaterally of the fourth ventricle and project through 
the superior cerebellar peduncle (Figs.  1, 3). They enter 
into the contralateral red nucleus after leaving the pons 
behind. The fibers proceed further to the thalamus, in the 
ventral anterior and ventral lateral nuclei. From this point 
they proceed their way to the medial part of the MC next 
to the midline (Figs. 4, 5). This doesn’t mean there is one 
axon arising from one point and finishing in another 
one. It is rather a bundle of fibers. The DRT traverses 
through his course the posterior subthalamic nucleus, 
zona incerta and the thalamus. It is situated medially of 
the CST in his course from the cerebellum to the thala-
mus (Figs. 2, 5). From the thalamus on, it proceeds medi-
ally and posteriorly of the CST further to the MC. From 
our point of view this is a very important finding. Fiber-
tracking from the MC in direction of the brainstem e.g. 
in case of the CST might include fibers of the DRT too. It 
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would be difficult for physicians to distinguish between 
these two tracts. We have to follow the DRT from the 
cerebellum up to the MC in order to be able to differenti-
ate between DRT and CST. The start of the DRT in the 
cerebellum and the further course of the CST through 
the brainstem give us the possibility of differentiation 
between the two. The fibers were tracked from the thala-
mus to the MC. We segmented the MC before this step. 
It is possible to use a ROI instead of the segmented area. 
From our point of view we can delineate the MC bet-
ter if we segment it. The differentiation between this 
tract and other WMTs is possible if we follow the fibers 
in their whole course from the DN in the cerebellum. 
Other thalamocortical fibers do not have their starting 
point there. We think that fibers which run through these 
points belong to the DRT and not to another tract. In our 
study the results of these WMT were anatomically repro-
ducible. The relation between these two WMT did not 
differ from one patient to another. We have to say, how-
ever, that the density of the fibers was not the same in all 
our patients. Some of the patients presented with a much 
higher density of fibers like the patient in Fig. 3 whereas 




DTI is a technique which can visualize WMT in vivo in 
healthy and non healthy patients by measuring aniso-
tropic water diffusion of the brain [18–20]. This tech-
nique has been used increasingly in recent years by 
neurosurgeons to identify WMT and deal with tumours 
in eloquent areas of the brain in order to reduce postop-
erative morbidity [21]. Some of these WMT include the 
Fig. 1 T1‑image, anterior view, Parkinson’s disease. Blue left corti‑
cospinal tract, Yellow right corticospinal tract, Gold left dentatoru‑
brothalamic tract, Bright purple right dentatorubrothalamic tract
Fig. 2 T1‑image, anterior view, multiple sclerosis. Blue left corticospi‑
nal tract, Yellow right corticospinal tract, Gold left dentatorubrotha‑
lamic tract, Bright purple right dentatorubrothalamic tract
Fig. 3 T1‑image, semilateral view from left, Parkinson’s disease. Blue 
left corticospinal tract, Yellow right corticospinal tract, Gold left den‑
tatorubrothalamic tract, Bright purple right dentatorubrothalamic tract
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visual pathway, the arcuate fasciculus or the CST. Addi-
tionally DTI might be a useful tool in patients with PD. 
It has a good sensitivity and specificity to differentiate 
between healthy subjects and de novo patients [3, 22].
DRT‑introduction
The portrayal of other WMT like the DRT might be also 
of considerable importance for neurosurgeons during 
DBS in patients with PD for tremor control. This tract 
has its starting point in the cerebellum in the DN, then 
it continues to the contralateral red nucleus and ventral 
anterolateral nuclei of thalamus from where the fibers 
proceed to the MC [23]. This WMT possesses not only 
motoric but also linguistic and cognitive functions [24]. 
Injury of this tract might lead to movement disorders like 
ataxia or tremor [25–27]. It has been suggested that dam-
age in the white matter integrity in the posterior portion 
might be responsible for motor symptoms while altera-
tions in the ventral part might be related to communica-
tion behaviour in patients with autism [23].
DRT‑anatomy and review of the literature
There have been two publications which suggest that 
tremor control with low voltages in the posterior sub-
thalamic region might be attributed to stimulation of 
the DRT [11, 28]. As this region is a station of the DRT 
in his course to the thalamus, this might be very well 
possible. Coenen et  al. [11] have provided a case where 
stimulation of this tract was directly involved in tremor 
reduction. Furthermore they emphasize that we are actu-
ally dealing with one fiber structure during DBS and this 
is the DRT [29]. A stimulation might not be sufficient 
if it doesn’t affect enough fibers of DRT. If it is far ante-
rior tremor reduction might not be satisfactory and if it 
is far posterior we might stimulate the medial lemniscus 
[29]. By knowing the exact position of the electrode and 
its angle to the stimulated cerebral structure we might 
be able to predict the necessary voltages needed for 
adequate results. Depending on the stimulated part of 
DRT we might achieve different results in tremor control 
and avoid side effects. That means we might be able to 
increase the voltage more if the electrode is far enough 
of certain structures like the CST. We have to be aware 
of the fact that the CST runs laterally of the DRT (Fig. 2).
DRT‑stimulation site
Depending on the position of the electrode the CST 
might be affected by a high voltage if the electrode is situ-
ated in the lateral portion of the DRT or by the electrode 
itself if this one is localized outside the DRT. There have 
been suggestions that the optimal position is inside in the 
anterior third of the DRT [29]. By means of DTI, it might 
be, however, difficult to portray WMT completely and 
in that case it might be difficult to determine the ante-
rior third of the DRT exactly. Another study, however, 
published by another group suggests that tremor reduc-
tion is better achieved if we stimulate directly inside the 
DRT [30]. Another option seems to be the stimulation 
in the quadrant posterior, inferior and lateral to it [30]. 
Although the DRT seems to be an important structure in 
DBS we have to emphasize the fact that the optimal elec-
trode placement is not so clear. However, we deem neces-
sary to emphasize the fact that the DRT proceeds next to 
the CST after leaving the thalamus (Figs. 1, 2, 3, 4, 5). A 
stimulation in that area might have eventual unintended 
side effects in the patients. We propose every stimula-
tion should occur caudally to this cerebral area. There-
fore, from our point of view, a depiction of both tracts, 
the DRT and CST, before DBS is important. If the elec-
tric field influences neighbouring regions like the CST, it 
might compromise our results. Our results show that the 
CST is localized laterally to the fibers of DRT (Figs. 1, 2, 
3, 4, 5). Therefore, we need to be very cautious when we 
stimulate laterally in order to avoid unwanted side effects. 
The accurate knowledge of the electrode placement after 
DBS might give additional information of tremor control 
in patients with PD or other forms of tremor. Another 
important issue which we need to mention is that we 
might not be able to stimulate the DRT everywhere 
in his course e.g. in the DN or red nucleus and achieve 
the same results as when we stimulate the subthalamic 
nucleus. By knowing the exact position of the electrode 
Fig. 4 T1‑image, semilateral view from right, Parkinson’s disease. Blue 
left corticospinal tract, Yellow right corticospinal tract, Gold left den‑
tatorubrothalamic tract, Bright purple right dentatorubrothalamic tract
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and its angle to the stimulated cerebral structure we 
might be able to predict the necessary voltages needed 
for adequate results. Depending on the stimulated part of 
DRT we might achieve different results in tremor control 
and avoid side effects. That means we might be able to 
increase the voltage more if the electrode is far enough 
of certain structures like the CST. A recently published 
study, however, has revealed that stimulation closer to 
the DRT doesn’t provide better results than more distant 
stimulation [30]. However, even if the results don’t seem 
to be better we should be carefully taking into account 
the volume of tissue activated in order to avoid side 
effects [31]. Besides to its motoric functions this WMT 
possesses linguistic and cognitive functions too [24]. An 
injury of DRT leads to cognitive and behavioural deficits, 
speech impairment or emotional lability [24]. Patients 
with PD develop these symptoms in the course of their 
disease, therefore a degeneration of this tract might 
explain this phenomenon. Further work needs to be done 
in order to deal with these symptoms.
PD affects the thalamus
Postmortem studies show that PD affects the thalamus 
in its own way [3]. It can provoke a degeneration or dis-
ruption of the microstructural integrity of the thalamus 
[3, 32, 33]. As we mentioned above the thalamus is a 
region which is crossed by the DRT. A degeneration or 
disruption of this region might induce a degeneration or 
disruption of this WMT and ultimately be one of the rea-
sons for PD. It seems not to be known how many fibers 
of this tract need to be stimulated in order to have sat-
isfactory results [29]. However, this might be depend-
ent on the progress of the disease and the grade of fiber 
degeneration.
DTI‑limitations
DTI was used for the visualization of DRT and CST. It 
has, however, some limitations. It is difficult to deter-
mine with accuracy the starting point and ending point 
of the fibers [34, 35]. The resolution of crossing or kiss-
ing fibers remains also a problem which should be taken 
into account [34, 35]. Nevertheless, the portrayal of these 
tracts was reproducible in nine different patients on dif-
ferent times. The DRT were all similar in their form and 
their relation to the CST, so we believe that the accuracy 
of our results remains high.
Limitations of the study
The authors are aware of the limitations of the current 
study. On one hand we are portraying here a small num-
ber of patients and on the other hand there is no control 
group. However, we have to say that, when compared to 
the existing literature, we found that our results concern-
ing the depiction of the DRT are in accordance with the 
results of other authors who have worked in this direction. 
Coenen et al. [17] confirm that the DRT traverses the thala-
mus, zona incerta and the STN. They add that this WMT is 
located in the proximity of the CST. In our cases Figs. 1, 2, 
3, 4 and 5 we localised the DRT medially to the CST. Other 
studies name the superior cerebellar peduncle, the DN and 
the thalamus as structures traversed by the DRT [25]. We 
can confirm that. Despite the small group of patients our 
results are in accordance with the existing literature.
On the other hand, further limitations concern the 
portrayal of WMT by means of DTI, e.g. the portrayal of 
crossing or kissing fibers might be difficult and the fact 
that the starting and ending point of the WMT cannot be 
visualized correctly [34, 35]. When two WMT are running 
in the proximity of each other then DTI will have to dis-
tinguish which fibers belong to one tract and which fibers 
belong to the other. Therefore, there is a risk that fibers 
of the smaller tract might be included to the fibers of the 
other one. Making the difference between the two might 
be difficult for physicians. In our case we have fibers of the 
DRT and CST. In the Figs. 1, 2, 3, 4 and 5 we see different 
tracts by using different colours, however, we have to take 
into account that some fibers might be attributed to the 
bigger tract due to the limitation mentioned above. Patient 
motion might be another limitation of the DTI [35]. Diffu-
sion MRI is very sensitive to motion [35]. Therefore, DTI 
might be difficult in patients suffering from PD.
Fig. 5 T1‑image, anterior view, Parkinson’s disease. Blue left corti‑
cospinal tract, Yellow right corticospinal tract, Gold left dentatoru‑
brothalamic tract, Bright purple right dentatorubrothalamic tract
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Conclusion
Our study shows that portrayal of DRT fibers is pos-
sible for everyday routine use with a little amount of 
time. All the results are easily reproducible. From our 
point of view it is necessary to visualize the CST along 
with the DRT before surgery in order to have a better 
idea about the relation between these two WMT which 
are situated very close to each other in order to avoid 
unwanted side effects postoperatively (Fig. 5). Identifi-
cation of DRT can be useful for physicians in control-
ling tremor.
Abbreviations
ADC: apparent diffusion coefficient; ASSET: array spatial sensitivity encoding 
technique; CST: corticospinal tract; DBS: deep brain stimulation; DN: dentate 
nucleus; DRT: dentatorubrothalamic tract; DTI: diffusion tensor imaging; EPI: 
echo planar imaging; FA: fractional anisotropy; FACT: fiber assignment by 
continuous tracking; FOV: field of view; MC: motor cortex; MRI: magnetic 
resonance imaging; MS: multiple sclerosis; PD: Parkinson’s disease; ROI: region 
of interest; WMT: white matter tracts.
Authors’ contributions
AH wrote the article, he took the patients in charge, he performed the DTI. 
AH revised the manuscript, she was in charge of literature control. GD was in 
charge of the MRI, he gave substantial information of the anatomical localiza‑
tions of the structures, he revised the manuscript. HB‑S revised the manu‑
script. FH revised the manuscript, he made the corrections, he operated the 
patients. All authors read and approved the final manuscript.
Author details
1 National Service of Neurosurgery, Centre Hospitalier de Luxembourg, Rue 
Barblé 25, 1210 Luxembourg, Luxembourg. 2 Internal Medicine Rotterdam, 
Erasmus University Rotterdam, Rotterdam, The Netherlands. 3 Service of Neu‑
roradiology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. 
Acknowledgements
We would like to thank the Department of Neuroradiology of the Centre 
Hospitalier de Luxembourg.
Competing interests
The authors declare that they have no competing interests.
Consent
All patients gave their consent to participate in the study.
Ethic approval and consent to participate
This study was approved by the ethic committee of the Centre Hospitalier de 
Luxembourg. The patients gave their consent to participate in this study.
Received: 30 January 2016   Accepted: 13 July 2016
References
 1. Keeney PM, Xie J. Capaldi RA Parkinson’s disease brain mitochondrial 
complex I has oxidatively damaged subunits and is functionally impaired 
and misassembled. J Neurosci. 2006;26(19):5256–64.
 2. Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, et al. Imaging 
prodromal Parkinson disease: the Parkinson associated risk syndrome 
study. Neurology. 2014;83(19):1739–46.
 3. Planetta PJ, Schulze ET, Geary EK, Corcos DM, Goldman JG, Little DM, et al. 
Thalamic projection fiber integrity in de novo Parkinson disease. AJNR 
Am J Neuroradiol. 2013;34(1):74–9.
 4. Tremblay C, Achim AM, Macoir J, Monetta L. The heterogeneity of cogni‑
tive symptoms in Parkinson’s disease: a meta‑analysis. J Neurol Neurosurg 
Psychiatry. 2013;84(11):126572.
 5. Taylor AE, Saint‑Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson’s 
disease. The cortical focus of neostriatal outflow. Brain. 1986;109(Pt 
5):845–83.
 6. Martínez‑Horta S, Riba J, de Bobadilla RF, Pagonabarraga J, Pascual‑
Sedano B, Antonijoan RM, et al. Apathy in Parkinson’s disease: neuro‑
physiological evidence of impaired incentive processing. J Neurosci. 
2014;34(17):5918–26.
 7. Karas PJ, Mikell CB, Christian E, Liker MA, Sheth SA. Deep brain stimula‑
tion: a mechanistic and clinical update. Neurosurg Focus. 2013;35(5):E1.
 8. Okun MS. Deep‑brain stimulation for Parkinson’s disease. N Engl J Med. 
2012;367(16):1529–38.
 9. Mädler B, Coenen VA. Explaining clinical effects of deep brain stimulation 
through simplified target‑specific modeling of the volume of activated 
tissue. AJNR Am J Neuroradiol. 2012;33(6):1072–80.
 10. Perlmutter JS, Mink JW. Deep brain stimulation. Annu Rev Neurosci. 
2006;29:229–57.
 11. Coenen VA, Mädler B, Schiffbauer H, Urbach H, Allert N. Individual fiber 
anatomy of the subthalamic region revealed with diffusion tensor imag‑
ing: a concept to identify the deep brain stimulation target for tremor 
suppression. Neurosurgery. 2011;68(4):1069–75 (discussion 1075–6).
 12. Fasano A, Daniele A, Albanese A. Treatment of motor and non‑motor fea‑
tures of Parkinson’s disease with deep brain stimulation. Lancet Neurol. 
2012;11(5):429–42.
 13. Yamamoto A, Miki Y, Urayama S, Fushimi Y, Okada T, Hanakawa T, et al. 
Diffusion tensor fiber tractography of the optic radiation: analysis with 
6‑, 12‑, 40‑, and 81‑directional motion‑probing gradients, a preliminary 
study. AJNR Am J Neuroradiol. 2007;28(1):92–6.
 14. Nucifora PG, Verma R, Lee SK, Melhem ER. Diffusion‑tensor MR imaging 
and tractography: exploring brain microstructure and connectivity. 
Radiology. 2007;245(2):367–84.
 15. Coenen VA, Honey CR, Hurwitz T, Rahman AA, McMaster J, Bürgel U, et al. 
Medial forebrain bundle stimulation as a pathophysiological mechanism 
for hypomania in subthalamic nucleus deep brain stimulation for Parkin‑
son’s disease. Neurosurgery. 2009;64(6):1106–14 (discussion 1114–5).
 16. Akakin A, Peris‑Celda M, Kilic T, Seker A, Gutierrez‑Martin A, Rhoton A Jr. 
The dentate nucleus and its projection system in the human cerebel‑
lum: the dentate nucleus microsurgical anatomical study. Neurosurgery. 
2014;74(4):401–24.
 17. Coenen VA, Allert N, Mädler B. A role of diffusion tensor imaging fiber 
tracking in deep brain stimulation surgery: DBS of the dentato‑rubro‑
thalamic tract (drt) for the treatment of therapy‑refractory tremor. Acta 
Neurochir (Wien). 2011;153(8):1579–85.
 18. Martino J, da Silva‑Freitas R, Caballero H, Marco de Lucas E, García‑Porrero 
JA, Vázquez‑Barquero A. Fiber dissection and diffusion tensor imaging 
tractography study of the temporoparietal fiber intersection area. Neuro‑
surgery. 2013;72(1 Suppl Operative):87–97 (discussion 97–8).
 19. Cirillo M, Esposito F, Tedeschi G, Caiazzo G, Sagnelli A, Piccirillo G, et al. 
Widespread microstructural white matter involvement in amyotrophic 
lateral sclerosis: a whole‑brain DTI study. AJNR Am J Neuroradiol. 
2012;33(6):1102–8.
 20. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues 
elucidated by quantitative‑diffusion‑tensor MRI. 1996. J Magn Reson. 
2011;213(2):560–70.
 21. Fernandez‑Miranda JC, Pathak S, Engh J, Verstynen T, Yeh FC, Wang Y, 
et al. High‑definition fiber tractography of the human brain: neuro‑
anatomical validation and neurosurgical applications. Neurosurgery. 
2012;71(2):430–53.
 22. Vaillancourt DE, Spraker MB, Prodoehl J, Corcos DM, Zhou XJ, Comella CL, 
et al. High‑resolution diffusion tensor imaging in the substantia nigra of 
de novo Parkinson disease. Neurology. 2009;72(16):1378–84.
 23. Jeong JW, Chugani DC, Behen ME, Tiwari VN, Chugani HT. Altered white 
matter structure of the dentatorubrothalamic pathway in children with 
autistic spectrum disorders. Cerebellum. 2012;11(4):957–71.
 24. Perreault S, Lober RM, Cheshier S, Partap S, Edwards MS, Yeom KW. 
Time‑dependent structural changes of the dentatothalamic pathway 
in children treated for posterior fossa tumor. AJNR Am J Neuroradiol. 
2014;35(4):803–7.
Page 7 of 7Hana et al. BMC Res Notes  (2016) 9:345 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 25. Kwon HG, Hong JH, Hong CP, Lee DH, Ahn SH, Jang SH. Dentatoru‑
brothalamic tract in human brain: diffusion tensor tractography study. 
Neuroradiology. 2011;53(10):787–91.
 26. Marx JJ, Iannetti GD, Thömke F, Fitzek S, Galeotti F, Truini A, et al. Topodi‑
agnostic implications of hemiataxia: an MRI‑based brainstem mapping 
analysis. Neuroimage. 2008;39(4):1625–32.
 27. Lehéricy S, Grand S, Pollak P, Poupon F, Le Bas JF, Limousin P, et al. Clinical 
characteristics and topography of lesions in movement disorders due to 
thalamic lesions. Neurology. 2001;57(6):1055–66.
 28. Plaha P, Patel NK, Gill SS. Stimulation of the subthalamic region for essen‑
tial tremor. J Neurosurg. 2004;101(1):48–54.
 29. Coenen VA, Allert N, Paus S, Urbach H, Mädler B. Modulation of the 
cerebello‑thalamo‑cortical network in thalamic deep brain stimula‑
tion for tremor: a diffusion tensor imaging study. Neurosurgery. 
2014;75(6):657–69.
 30. Schlaier J, Anthofer J, Steib K, Fellner C, Rothenfusser E, Brawanski A, et al. 
Deep brain stimulation for essential tremor: targeting the dentato‑rubro‑
thalamic tract? Neuromodulation. 2014. doi:10.1111/ner.12238.
 31. Butson CR, Cooper SE, Henderson JM, McIntyre CC. Patient‑specific 
analysis of the volume of tissue activated during deep brain stimulation. 
Neuroimage. 2007;34(2):661–70 (Epub 2006 Nov 17).
 32. Brooks D, Halliday GM. Intralaminar nuclei of the thalamus in Lewy body 
diseases. Brain Res Bull. 2009;78(2–3):97–104.
 33. Henderson JM, Carpenter K, Cartwright H, Halliday GM. Loss of thalamic 
intralaminar nuclei in progressive supranuclear palsy and Parkinson’s dis‑
ease: clinical and therapeutic implications. Brain. 2000;123(Pt 7):1410–21.
 34. Alexander DC, Barker GJ. Optimal imaging parameters for fiber‑orienta‑
tion estimation in diffusion MRI. Neuroimage. 2005;27(2):357–67.
 35. Le Bihan D, Poupon C, Amadon A, Lethimonnier F. Artifacts and pitfalls in 
diffusion MRI. J Magn Reson Imaging. 2006;24(3):478–88.
